학술논문

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron
Document Type
Article
Source
In: iScience. (iScience, 21 April 2023, 26(4))
Subject
Language
English
ISSN
25890042